Companies: 10,795·Total market cap: $144.5T
Agilon Health, Inc.

Agilon Health, Inc.

AGLNYSEHealthcare● Active
$96.85
+$1.62(+1.70%)
Market Cap$1.6B
P/E Ratio
52W High$99.135
52W Low$7.48

Agilon Health, Inc. (AGL) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

agl · stock forecast · 25 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 25 Wall Street analysts in the past 3 months

SellBuy

Hold

25 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
8
Hold
15
Sell
2
Strong Sell
0
Total: 25 · Buy rate: 32.0%

12-Month Price Target

High

$81.00

Consensus

$53.20

-45.1% upside

Low

$16.00

Median: $49 · Last Close: $96.85

The Agilon Health, Inc. (AGL) analyst consensus is Hold, based on ratings from 25 Wall Street analysts over the past 3 months. The average 12-month AGL price target is $53.20, representing -45.1% upside from the current price of $96.85.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $53 (-45.1%)

Consensus Target

$53.20

-45.1% upside

High Target

$81

-16.4%

Low Target

$16

-83.5%

Current Price

$96.85

as of today

Based on analyst price targets, the AGL stock price prediction for the next 12 months ranges from $16 to $81. The consensus AGL price forecast of $53.20 implies -45.1% upside from the current price of $96.85.

Short-Term Price Prediction

Bull

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$101.695.00%

1-day model range: $97.44–$105.95. Peak: $105.95 (+5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$48-50.0%
2028$35-63.8%
2029$30-69.2%
2030$27-71.8%
2031-73.1%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

93%7%0%
13Buy
1Neutral
0Sell
RSI (14)64.5Neutral
MACDBULLISH

Refreshes daily from EOD close

Moving Averages · AGL · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$90.81BUY
MA 10$89.86BUY
MA 20$82.54BUY
MA 50$46.82BUY
MA 100$31.46BUY
MA 200$26.94BUY
Current $AGL · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$92.07BUY
EMA 10$88.67BUY
EMA 20$79.10BUY
EMA 50$56.70BUY
EMA 100$41.90BUY
EMA 200$39.34BUY
Current $AGL · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Barclays2026-05-26
Upgrade ↑
UnderweightEqual Weight
Benchmark2026-05-21
Maintains
BuyBuy
Citigroup2026-05-15
Maintains
NeutralNeutral
TD Cowen2026-05-11
Maintains
HoldHold
Wells Fargo2026-05-08
Maintains
OverweightOverweight
Jefferies2026-05-07
Upgrade ↑
HoldBuy
Baird2026-05-07
Maintains
NeutralNeutral
Deutsche Bank2026-05-07
Upgrade ↑
HoldBuy
Evercore ISI Group2026-05-07
Maintains
In LineIn Line
JP Morgan2026-05-04
Downgrade ↓
NeutralUnderweight

Wall Street analysts have recently issued updated ratings on Agilon Health, Inc. (AGL) stock. Of the recent 115 rating actions, 6 were upgrades and 13 were downgrades. 25 analysts currently cover AGL.

Analyst Recommendation Trends

Buy ratings14↑ +3
Hold ratings05↑ +5
Sell ratings01↑ +1

AGL analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 4 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$5.7B

↓ 15.7% YoY

Revenue Next Year

$6.1B

↑ 6.3% YoY

EPS This Year

$-2.84

EPS Next Year

$-0.99

↓ 65.1% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast AGL EPS of $-2.84 for the current fiscal year, based on estimates from 9 analysts. The AGL revenue forecast is $5.7B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The AGL stock forecast is supported by two independent data sources: analyst consensus ratings from 25 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AGL price target is $53.20 (-45.1% upside), with an analyst consensus of Hold.

The AGL short-term stock prediction for tomorrow is $101.69 (+5.00%). The AGL stock price prediction for 2027 estimates an average of $48. The AGL stock prediction for 2030 projects a range of $15–$40.

Agilon Health, Inc. trades on NYSE under the ticker AGL. The AGL stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 32% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

AGL forecast · 8 questions

According to 25 Wall Street analysts, the average 12-month AGL price target is $53.20, with a high forecast of $81.00 and a low of $16.00. The median price target is shown in the chart above when available. This implies -45.1% potential upside from the current price of $96.85.

AGL price targetWhat is AGL price targetAGL analyst price targetAGL 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.